检索结果 - Christine Chevreau

Refine Results
  1. 1
    Sorafenib-Induced Eruptive Melanocytic Lesions

    Sorafenib-Induced Eruptive Melanocytic Lesions 由 Heidi H. Kong, V. Sibaud, Maria L. Turner, Tito Fojo, Thomas J. Hornyak, Christine Chevreau

    出版 2008
    获取全文
    Carta
    加到收藏夹
    Saved in:
  2. 2
    Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis

    Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis 由 Benjamin Besse, Dominique Grunenwald, Aude Fléchon, Armelle Caty, Christine Chevreau, Stéphane Culine, Christine Théodore, Karim Fizazi

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Fertility after testicular cancer treatments

    Fertility after testicular cancer treatments 由 É. Huyghe, Tomohiro Matsuda, Myriam Daudin, Christine Chevreau, Jean‐Marc Bachaud, Pierre Plante, Louis Bujan, Patrick Thonneau

    出版 2004
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis

    Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis 由 Sylvie Négrier, David Pérol, Alain Ravaud, Christine Chevreau, Jacques‐Olivier Bay, R. Delva, Emmanuel Sevin, Armelle Caty, Bernard Escudier

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie

    Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie 由 Sylvie Négrier, Bernard Escudier, F. Gómez, Jean‐Yves Douillard, Alain Ravaud, Christine Chevreau, M Buclon, David Pérol, Christine Lasset

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors

    Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors 由 Patricia Pautier, M. Gutierrez-Bonnaire, A. Rey, I. Sillet-Bach, Christine Chevreau, Pierre Kerbrat, Philippe Morice, Pierre Duvillard, C. Lhommé

    出版 2007
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    HFS-14, a Specific Quality of Life Scale Developed for Patients Suffering from Hand–Foot Syndrome

    HFS-14, a Specific Quality of Life Scale Developed for Patients Suffering from Hand–Foot Syndrome 由 V. Sibaud, Florence Dalenc, Christine Chevreau, Henri Roché, Jean‐Pierre Delord, Loı̈c Mourey, Jean‐Louis Lacaze, Nora Rahhali, C. Taïeb

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Zika virus in semen of a patient returning from a non-epidemic area

    Zika virus in semen of a patient returning from a non-epidemic area 由 Jean‐Michel Mansuy, Christophe Pasquier, Myriam Daudin, Sabine Chapuy‐Regaud, Nathalie Moinard, Christine Chevreau, Jacques Izopet, Catherine Mengelle, Louis Bujan

    出版 2016
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  9. 9
    A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases

    A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases 由 Christine Chevreau, Alain Ravaud, Bernard Escudier, Éric Amela, R. Delva, Frédéric Rolland, Diégo Tosi, Stéphane Oudard, Ellen Blanc, Céline Ferlay, Sylvie Négrier

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Interleukin-6, Interleukin-10, and Vascular Endothelial Growth Factor in Metastatic Renal Cell Carcinoma: Prognostic Value of Interleukin-6—From the Groupe Français d'Immunothérapie

    Interleukin-6, Interleukin-10, and Vascular Endothelial Growth Factor in Metastatic Renal Cell Carcinoma: Prognostic Value of Interleukin-6—From the Groupe Français d'Immunothérapi... 由 Sylvie Négrier, David Pérol, Christine Ménétrier‐Caux, Bernard Escudier, Michel Pallardy, Alain Ravaud, Jean‐Yves Douillard, Christine Chevreau, Christine Lasset, Jean‐Yves Blay

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

    Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma 由 Sylvie Négrier, Bernard Escudier, Christine Lasset, Jean‐Yves Douillard, J. Savary, Christine Chevreau, Alain Ravaud, A. Mercatello, J Pény, Mireille Mousseau, Thierry Philip, Thomas Tursz

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis

    Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemi... 由 A. Aboudaram, Léonor Chaltiel, Damien Pouessel, P. Gräff, Nicolas Benziane-Ouaritini, Paul Sargos, Ulrike Schick, G. Créhange, Elizabeth Cohen‐Jonathan Moyal, Christine Chevreau, Jonathan Khalifa

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions

    Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions 由 Sophie Le Guellec, Nicolas Macagno, Valérie Velasco, Laurence Lamant, Marick Laé, Thomas Filleron, Nausicaa Malissen, E. Cassagnau, Philippe Terrier, Christine Chevreau, Dominique Ranchère‐Vince, Jean‐Michel Coindre

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial

    Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial 由 Karim Fizazi, Gwénaëlle Gravis, A. Flechon, L. Geoffrois, Christine Chevreau, Brigitte Laguerre, R. Delva, J.C. Eymard, Frédéric Rolland, Nadine Houédé, A. Laplanche, Domnita-Ileana Burcoveanu, Stéphane Culine

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

    Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Canc... 由 Stéphane Culine, Pierre Kerbrat, A. Kramar, Christine Théodore, Christine Chevreau, Lionnel Geoffrois, N.B. Bui, J Pény, Armelle Caty, R. Delva, Pierre Biron, Karim Fizazi, J. Bouzy, Jean‐Pierre Droz

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

    Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase I... 由 Anna Patrikidou, Sylvie Chabaud, Isabelle Ray‐Coquard, B. Bui, Antoine Adenis, María Rios, François Bertucci, Florence Duffaud, Christine Chevreau, Didier Cupissol, Julien Dômont, David Pérol, Jean‐Yves Blay, Axel Le Cesne

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma

    First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma 由 Bohuslav Melichar, P. Koralewski, Alain Ravaud, A Płużańska, Sergio Bracarda, Cezary Szczylik, Christine Chevreau, M. Filipek, R. Delva, Emmanuel Sevin, Sylvie Négrier, J McKendrick, Armando Santoro, Pavel Pisa, Bernard Escudier

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment

    CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment 由 Jean‐Emmanuel Kurtz, Xavier Buy, Frédèric Deschamps, Erik Sauleau, Amine Bouhamama, Maud Toulmonde, Charles Honoré, François Bertucci, Mehdi Brahmi, Christine Chevreau, Florence Duffaud, Justine Gantzer, Julien Garnon, Jean‐Yves Blay, Afshin Gangi

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients With Intermediate- and Poor-Risk Metastatic Nonseminomatous Germ Cell Tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP

    Randomized Trial Comparing Bleomycin/Etoposide/Cisplatin With Alternating Cisplatin/Cyclophosphamide/Doxorubicin and Vinblastine/Bleomycin Regimens of Chemotherapy for Patients Wit... 由 Stéphane Culine, Andrew Kramar, Christine Théodore, L. Geoffrois, Christine Chevreau, Pierre Biron, Binh Bui Nguyen, Jean‐François Héron, Pierre Kerbrat, Armelle Caty, R. Delva, P. Fargeot, Karim Fizazi, Jeannine Bouzy, Jean‐Pierre Droz

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

    Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas 由 Maud Toulmonde, Nicolas Penel, Julien Adam, Christine Chevreau, Jean‐Yves Blay, Axel Le Cesne, Emmanuelle Bompas, Sophie Piperno‐Neumann, Sophie Cousin, Thomas Grellety, Thomas Ryckewaert, Alban Bessede, François Ghiringhelli, Marina Pulido, Antoîne Italiano

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: